Our previous work identified a novel interaction between KRAS and AGO2 in both WT and mutant KRAS cell lines across multiple cell lineages and cancers via coimmunoprecipitation (Co-IP) followed by mass spectrometry (co-IP MS) (9). The gene discussed is KRAS; the disease is cancer.